HCPCS Code J7626

Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg

Drugs administered other than oral method, chemotherapy drugs

J7626 is a valid 2023 HCPCS code for Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg or just “Budesonide non-comp unit” for short, used in Medical care.

HCPCS Code Details - J7626

HCPCS Level II Code
Drugs administered other than oral method, chemotherapy drugs
HCPCS Code J7626
Description

Long description:
Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg

Short description:
Budesonide non-comp unit

HCPCS Modifier1
HCPCS Pricing indicator 51 - Drugs
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Coverage code C - Carrier judgment
BETOS2 code D1G - Drugs Administered through DME
HCPCS Action code N - No maintenance for this code
Type of service 1 - Medical care
Effective date Effective Jan 01, 2007
Date added Added Jan 01, 2002
HCPCS Coding Procedures

HCPCS Modifiers

In HCPCS Level II, modifiers are composed of two alpha or alphanumeric characters.

Example: E0260-NU - Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress
“NU” identifies the hospital bed as new equipment

ASP Drug pricing - J7626

Effective Code Dosage Payment
Limit		 Vaccine AWP % Vaccine Limit Infusion AWP % DME infusion limit Blood AWP % Blood limit Clotting factor Note
April 1, 2023 - June 30, 2023 0.5 MG 0.899 20% - - - - -
January 1, 2023 - March 31, 2023 0.5 MG 0.868 - - - - - -
October 1, 2022 - December 31, 2022 0.5 MG 0.964 - - - - - -
Jul 1, 2022 - Sep 30, 2022 0.5 MG 1.044 - - - - - -
April 1, 2022 - June 30, 2022 0.5 MG 1.033 - - - - - -

See also

  • HCPCS J7624 · Betamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram

  • HCPCS J7627 · Budesonide, inhalation solution, compounded product, administered through dme, unit dose form, up to 0.5 mg

  • HCPCS J7633 · Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram

  • HCPCS J7634 · Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram

1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”